ACMES 2025 Annual Meeting Hold in Boston

Spotlight on Medical Advances and Future Trends

Boston, September 14, 2025 — The American Chinese Medical Exchange Society (ACMES) convened its annual meeting, Medical Advances 2025, at the Sherman Auditorium, Beth Israel Deaconess Medical Center (BIDMC). More than a hundred faculty and leaders from Harvard Medical School, Massachusetts General Hospital (MGH), BIDMC, Boston Children’s Hospital, NYU, Duke University, University of Houston, Shanghai General Hospital (Shanghai First People’s Hospital), Zhejiang University, and other institutions joined healthcare industry representatives to discuss frontiers and future directions in medicine.

Opening

ACMES President Xue-Jun Kong, MD (Harvard Medical School) delivered welcoming remarks, reaffirming ACMES’s mission to unite clinicians, elevate medical education and care quality, build exchange platforms, and advance global health. She highlighted AI, precision medicine, and cross-disciplinary collaboration as core drivers of the next era.

Program Highlights

• Is Hepatitis D an “orphan disease”? — Daryl Lau, MD (HMS/BIDMC) underscored under-recognized HDV burden; in 42 countries HDV prevalence reaches 2–3%, and up to 7.2% in some groups. She advocated HBV/HDV co-screening and early education, with attention to coinfection comorbidities and treatment.
• Anti-obesity therapeutics in practice — Zhao Liu, MD (BIDMC–Lahey) outlined indications, selection strategies, and cautions; agents show strong potential for weight loss and metabolic improvement.
• MASH updates — Calvin Pan, MD (NYU) reviewed current diagnostics, management, and research progress.
• Endocrine events from cancer immunotherapy — Min Le, MD (Brigham and Women’s Hospital) presented recognition and management pearls, calling for vigilance, early intervention, and cross-disciplinary care.
• Transformation of China’s public hospitals — Jun Liu, MD (Shanghai General Hospital) shared practices and lessons learned.
• Gut–brain axis in ASD and AD — Xue-Jun Kong, MD (MGH) and Chongzhao Ran, PhD (MGH) discussed mechanisms and translational work, arguing that future psychiatric diagnostics and interventions must integrate precision medicine and multidisciplinary approaches.
• AI reshaping healthcare — Gary Lu, MD, MS, PhD (ACMES Secretary-General) and Weigen Li, MD, PhD (ACMES Vice President; BIDMC–Plymouth) showed how AI augments clinicians— “not replacing doctors but giving them an extra pair of x-ray eyes.”
• China healthcare industry trends & opportunities — Linhai Chen (National Private Medicine Development Network) outlined collaboration pathways.
• Treatment-resistant depression (TRD) — Ping Cui, MD (Holy Family Hospital) summarized evolving therapies.
• From clinic to innovation — Jim Wu, MD, MBA (Global Health Interactive) mapped routes for physician entrepreneurship: progress hinges on research–industry–innovation working together.

Dialogue & Takeaways

Panels examined AI × medicine, care-delivery transformation, and cross-border collaboration. Speakers repeatedly emphasized collaboration, prevention, and AI, reflecting global trends. Delegates from China and Chinese American scholars expressed a shared vision to strengthen U.S.–China medical cooperation.

Closing

Participants agreed medicine is entering a new phase of collaboration–innovation–prevention. In closing remarks, Dr. Kong noted: “Everything we do is to move medicine forward and bring hope to more patients.”

Dinner Reception

A gala dinner at the InterContinental Boston was co-hosted by ACMES president Xue-Jun (June) Kong, MD and Jiansheng (Jason) Li, PhD (founder & chairman, Boston Anti-Aging Center). Guests included Harvard colleagues Frank Slack, PhD; Daniel Tenen, MD; Alexander K. Ebralidze, PhD; Sarah Morton, MD, PhD, etc; ACMES leaders from Boston and other states Lucy Chen, MD, Jianren Mao, MD, Weigen Li, MD, Zhao Liu, MD, Le Min, MD, etc, and 20+ CEOs and department chairs from Shanghai, Zhejiang, Tianjin, Henan, Guizhou, Beijing, among others, Massachusetts policymakers, Harvard Business School, and business leaders in Boston and New York for medical development. Two hosts both emphasized that integrating advanced medical technologies with high-end industries is crucial to driving global health—particularly in the field of healthy aging. ~60 attendees celebrated vigorous exchange between cutting-edge medicine and high-tech industry.